The principal excitatory neurotransmitter in the vertebrate central ne
rvous system, L-glutamate, acts on three classes of ionotripic glutama
te receptors, named after the agonists AMPA a-amino-3-hydroxy-5-methyl
-4-isoxalole-4-propionic acid),NMDA (N-methyl-D-aspartate) and kainate
(1). The development of selective pharmacological agents has led to a
detailed understanding of the physiological and pathological roles of
AMPA and NMDA receptors(2-8). in contrast, the lack of selective kaina
te receptor ligands has greatly hindered progress in understanding the
roles of kainate receptors(9,10). Here we describe the effects of a p
otent and selective agonist, ATPA o-3-(3-hydroxy-5-tert-butylisoxazol-
4-yl)propanoic acid) and a selective antagonist, LY294486 ((3SR, 4aRS,
6SR, 8aRS)-6-((((1H-tetrazol-5-yl) methyl)oxy)methyl)-1, 2, 3, 4, 4a,
5, 6, 7, 8, 8a-decahydroisoquinoline-3-carboxylic acid), of the GluR5
subtype of kainate receptor(11). We have used these agents to show th
at kainate receptors, comprised of or containing GluR5 subunits, regul
ate synaptic inhibition in the hippocampus, an action that could contr
ibute to the epileptogenic effects of kainate(12-17).